ADCs: the next generation of targeted therapies
Drug Discovery World
SEPTEMBER 25, 2024
Antibody drug conjugates (ADCs) are among the hottest properties in pharma, powerful anticancer drugs that target tumours and deliver a lethal payload that destroys them, while leaving healthy tissues untouched. He adds: “The rise of ADCs as a priority for big pharma companies can be attributed to several factors.
Let's personalize your content